Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19405813rdf:typepubmed:Citationlld:pubmed
pubmed-article:19405813lifeskim:mentionsumls-concept:C0026845lld:lifeskim
pubmed-article:19405813lifeskim:mentionsumls-concept:C1457899lld:lifeskim
pubmed-article:19405813lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:19405813lifeskim:mentionsumls-concept:C0348016lld:lifeskim
pubmed-article:19405813lifeskim:mentionsumls-concept:C1705822lld:lifeskim
pubmed-article:19405813lifeskim:mentionsumls-concept:C0348011lld:lifeskim
pubmed-article:19405813lifeskim:mentionsumls-concept:C0181586lld:lifeskim
pubmed-article:19405813lifeskim:mentionsumls-concept:C0439834lld:lifeskim
pubmed-article:19405813lifeskim:mentionsumls-concept:C0456962lld:lifeskim
pubmed-article:19405813lifeskim:mentionsumls-concept:C0205373lld:lifeskim
pubmed-article:19405813lifeskim:mentionsumls-concept:C1709708lld:lifeskim
pubmed-article:19405813pubmed:issue2lld:pubmed
pubmed-article:19405813pubmed:dateCreated2009-5-7lld:pubmed
pubmed-article:19405813pubmed:abstractTextMyostatin is a member of the transformating growth factor-beta (TGF-beta) superfamily of proteins and is produced almost exclusively in skeletal muscle tissue, where it is secreted and circulates as a serum protein. Myostatin acts as a negative regulator of muscle mass through the canonical SMAD2/3/4 signaling pathway. Naturally occurring myostatin mutants exhibit a 'double muscling' phenotype in which muscle mass is dramatically increased as a result of both hypertrophy and hyperplasia. Myostatin is naturally inhibited by its own propeptide; therefore, we assessed the impact of adeno-associated virus-8 (AAV8) myostatin propeptide vectors when systemically introduced in MF-1 mice. We noted a significant systemic increase in muscle mass in both slow and fast muscle phenotypes, with no evidence of hyperplasia; however, the nuclei-to- cytoplasm ratio in all myofiber types was significantly reduced. An increase in muscle mass in slow (soleus) muscle led to an increase in force output; however, an increase in fast (extensor digitorum longus [EDL]) muscle mass did not increase force output. These results suggest that the use of gene therapeutic regimens of myostatin inhibition for age-related or disease-related muscle loss may have muscle-specific effects.lld:pubmed
pubmed-article:19405813pubmed:languageenglld:pubmed
pubmed-article:19405813pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19405813pubmed:citationSubsetIMlld:pubmed
pubmed-article:19405813pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19405813pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19405813pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19405813pubmed:statusMEDLINElld:pubmed
pubmed-article:19405813pubmed:monthAprlld:pubmed
pubmed-article:19405813pubmed:issn1557-8577lld:pubmed
pubmed-article:19405813pubmed:authorpubmed-author:LuberitzBBlld:pubmed
pubmed-article:19405813pubmed:authorpubmed-author:PatelKetanKlld:pubmed
pubmed-article:19405813pubmed:authorpubmed-author:GrahamIan RIRlld:pubmed
pubmed-article:19405813pubmed:authorpubmed-author:DicksonGeorge...lld:pubmed
pubmed-article:19405813pubmed:authorpubmed-author:WalshFrank...lld:pubmed
pubmed-article:19405813pubmed:authorpubmed-author:FosterHelenHlld:pubmed
pubmed-article:19405813pubmed:authorpubmed-author:YaworskyPaul...lld:pubmed
pubmed-article:19405813pubmed:authorpubmed-author:FosterKeithKlld:pubmed
pubmed-article:19405813pubmed:authorpubmed-author:TrolletCapuci...lld:pubmed
pubmed-article:19405813pubmed:authorpubmed-author:OttoAnthonyAlld:pubmed
pubmed-article:19405813pubmed:authorpubmed-author:BickhamDaleDlld:pubmed
pubmed-article:19405813pubmed:authorpubmed-author:KawarSusannah...lld:pubmed
pubmed-article:19405813pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19405813pubmed:volume12lld:pubmed
pubmed-article:19405813pubmed:ownerNLMlld:pubmed
pubmed-article:19405813pubmed:authorsCompleteYlld:pubmed
pubmed-article:19405813pubmed:pagination85-94lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:meshHeadingpubmed-meshheading:19405813...lld:pubmed
pubmed-article:19405813pubmed:year2009lld:pubmed
pubmed-article:19405813pubmed:articleTitleAdeno-associated virus-8-mediated intravenous transfer of myostatin propeptide leads to systemic functional improvements of slow but not fast muscle.lld:pubmed
pubmed-article:19405813pubmed:affiliationSWAN Institute of Biomedical and Life Sciences, School of Biological Sciences, Royal Holloway-University of London, Egham, UK.lld:pubmed
pubmed-article:19405813pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19405813lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19405813lld:pubmed